Previous Close
$1.02
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$45.0 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified ...
Community
- 0 posts discussing
0
Watchers
0
Visitors